The use of fluconazole and itraconazole in the treatment of Candida albicans infections: a review-Reference-Cited by-同舟云学术

The use of fluconazole and itraconazole in the treatment of Candida albicans infections: a review

Published:1999-10 Issue:4 Volume:44 Page:429-437
ISSN:1460-2091
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Martin Michael V.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/44/4/429/13057166/JAC444429.pdf

Reference93 articles.

1. Beck-Sagúe, C. & Jarvis, W. R. (1993). Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990. National Nocosomial Infections Surveillance System. Journal of Infectious Diseases167, 1247–51.

2. Dupont, P. F. (1995). Candida albicans, the opportunist. A cellular and molecular perspective. Journal of the American Pediatric Medical Association85, 104–15.

3. McCullough, M. J., Ross, B. C. & Reade, P. C. (1996). Candida albicans: a review of its history, taxonomy, epidemiology, virulence attributes, and methods of strain differentiation. International Journal of Oral and Maxillofacial Surgery25, 136–44.

4. Barchiesi, F., Morbiducci, V., Ancarani, F. & Scalise, G. (1993). Emergence of oropharyngeal candidiasis caused by non-albicans species of Candida in HIV-infected patients. European Journal of Epidemiology9, 455–6.

5. Powderly, W. G., Robinson, K. & Keath, E. J. (1993). Molecular epidemiology of recurrent oral candidiasis in human immunodeficiency virus-positive patients: evidence for two patterns of recurrence. Journal of Infectious Diseases168, 463–6.

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in triazole synthesis via click chemistry and their pharmacological applications: A review;Bioorganic & Medicinal Chemistry Letters;2024-11

2. Exploring triazole-based drugs: Synthesis, application, FDA approvals, and clinical trial updates–A comprehensive review;Tetrahedron;2024-08

3. Biomimetic and multifunctional nanocomposites for precision fungi theranostics;Biomaterials;2024-07

4. Ufosomes as Topical/Transdermal Drug Delivery System: Structural Components, Preparation Techniques and Therapeutic Application;Current Drug Delivery;2024-05-22

5. Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progression;Cancer Gene Therapy;2024-04-15